| Date | Time | Source | Announcement |
|---|---|---|---|
| 21 Jul 2015 | 03:40 PM | Holding(s) in Company | |
| 17 Jul 2015 | 12:26 PM | Director/PDMR Shareholding | |
| 07 Jul 2015 | 03:30 PM | Holding(s) in Company | |
| 03 Jul 2015 | 03:39 PM | Exercise of overallotment option - Admission | |
| 03 Jul 2015 | 07:01 AM | Exercise of Over-allotment Option | |
| 03 Jul 2015 | 07:00 AM | End of Stabilisation Notice | |
| 26 Jun 2015 | 03:18 PM | Holding(s) in Company | |
| 24 Jun 2015 | 04:25 PM | Holding(s) in Company | |
| 24 Jun 2015 | 08:00 AM | Admission to Trading on the London Stock Exchange | |
| 19 Jun 2015 | 02:17 PM | Publication of Prospectus | |
| 19 Jun 2015 | 07:01 AM | Stabilisation Notice | |
| 19 Jun 2015 | 07:00 AM | Raises $171m in Premium List Main Market IPO |
PureTech Health is a biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange under the ticker PRTC.
PureTech share price launched at 178p in 2015.